MDWD - MediWound stock climbs 9% on Phase 2 data for wound care treatment
2024-02-12 12:19:10 ET
More on MediWound
- MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript
- FDA accepts MediWound application for NexoBrid pediatric approval
- MediWound wins DoD funding to develop NexoBrid for U.S. Army
- Seeking Alpha’s Quant Rating on MediWound
- Historical earnings data for MediWound